Dr. Eric C. Buxton, M.D.
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- Columbia University College of Physicians and Surgeons (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 824
Licensed in California since 2002, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: Columbia University College of Physicians and Surgeons
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
CA license A78113 (first issued 2002; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UCSF Medical Center San Francisco, CA
- Peninsula Medical Center Burlingame, CA
- Marinhealth Medical Center Greenbrae, CA
- Novato Community Hospital Novato, CA
- Sonoma Valley Hospital Sonoma, CA
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 824
- Services billed
- 10,330
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 3,600 | 52 |
| Established patient office or other outpatient visit, 30-39 minutes | 897 | 609 |
| Established patient office or other outpatient visit, 40-54 minutes | 321 | 198 |
| Established patient office or other outpatient visit, 20-29 minutes | 115 | 104 |
| Injection of drug or substance under skin or into muscle | 71 | 56 |
| New patient office or other outpatient visit, 45-59 minutes | 59 | 59 |
| New patient office or other outpatient visit, 60-74 minutes | 18 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Synthroid (levothyroxine sodium) Other prescribers in San Francisco, CA | 863 |
| Levothyroxine Sodium Other prescribers in San Francisco, CA | 655 |
| Mounjaro (tirzepatide) Other prescribers in San Francisco, CA | 410 |
| Metformin Hcl Er (metformin hcl) Other prescribers in San Francisco, CA | 374 |
| Liothyronine Sodium Other prescribers in San Francisco, CA | 359 |
| Metformin Hcl Other prescribers in San Francisco, CA | 218 |
| Alendronate Sodium Other prescribers in San Francisco, CA | 201 |
| Ozempic (semaglutide) Other prescribers in San Francisco, CA | 179 |
| Trulicity (dulaglutide) Other prescribers in San Francisco, CA | 162 |
| Jardiance (empagliflozin) Other prescribers in San Francisco, CA | 150 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 23 companies reported 109 payments worth $2,097 in total to this clinician.
| Antares Pharma, Inc. | $326 |
|---|---|
| Lilly USA, LLC | $271 |
| Amgen Inc. | $250 |
| Novo Nordisk Inc | $220 |
| AbbVie Inc. | $166 |
| Madrigal Pharmaceuticals | $162 |
| Abbott Laboratories | $113 |
| Ascendis Pharma Endocrinology Inc | $85.34 |
| Food and Beverage | $2,073 |
|---|---|
| Education | $24.04 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Neurocrine Biosciences, Inc. May 13, 2025 | Education CRENESSITY · Neuropsychiatry · in-kind | $24.04 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.